176 related articles for article (PubMed ID: 10918583)
1. Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?
Meroni G; Cairo S; Merla G; Messali S; Brent R; Ballabio A; Reymond A
Oncogene; 2000 Jul; 19(29):3266-77. PubMed ID: 10918583
[TBL] [Abstract][Full Text] [Related]
2. MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network.
Billin AN; Eilers AL; Coulter KL; Logan JS; Ayer DE
Mol Cell Biol; 2000 Dec; 20(23):8845-54. PubMed ID: 11073985
[TBL] [Abstract][Full Text] [Related]
3. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors.
Billin AN; Eilers AL; Queva C; Ayer DE
J Biol Chem; 1999 Dec; 274(51):36344-50. PubMed ID: 10593926
[TBL] [Abstract][Full Text] [Related]
4. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor.
Meroni G; Reymond A; Alcalay M; Borsani G; Tanigami A; Tonlorenzi R; Lo Nigro C; Messali S; Zollo M; Ledbetter DH; Brent R; Ballabio A; Carrozzo R
EMBO J; 1997 May; 16(10):2892-906. PubMed ID: 9184233
[TBL] [Abstract][Full Text] [Related]
5. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
[TBL] [Abstract][Full Text] [Related]
6. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.
Grinberg AV; Hu CD; Kerppola TK
Mol Cell Biol; 2004 May; 24(10):4294-308. PubMed ID: 15121849
[TBL] [Abstract][Full Text] [Related]
7. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
8. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
[TBL] [Abstract][Full Text] [Related]
9. The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.
Lafita-Navarro MC; Liaño-Pons J; Quintanilla A; Varela I; Blanco R; Ourique F; Bretones G; Aresti J; Molina E; Carroll P; Hurlin P; Romero OA; Sanchez-Céspedes M; Eisenman RN; Delgado MD; León J
J Biol Chem; 2020 Feb; 295(7):2001-2017. PubMed ID: 31919096
[TBL] [Abstract][Full Text] [Related]
10. Design and properties of a Myc derivative that efficiently homodimerizes.
Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
[TBL] [Abstract][Full Text] [Related]
11. WBSCR14, a gene mapping to the Williams--Beuren syndrome deleted region, is a new member of the Mlx transcription factor network.
Cairo S; Merla G; Urbinati F; Ballabio A; Reymond A
Hum Mol Genet; 2001 Mar; 10(6):617-27. PubMed ID: 11230181
[TBL] [Abstract][Full Text] [Related]
12. A novel heterodimerization domain, CRM1, and 14-3-3 control subcellular localization of the MondoA-Mlx heterocomplex.
Eilers AL; Sundwall E; Lin M; Sullivan AA; Ayer DE
Mol Cell Biol; 2002 Dec; 22(24):8514-26. PubMed ID: 12446771
[TBL] [Abstract][Full Text] [Related]
13. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
Hurlin PJ; Quéva C; Eisenman RN
Genes Dev; 1997 Jan; 11(1):44-58. PubMed ID: 9000049
[TBL] [Abstract][Full Text] [Related]
14. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
Lüscher B; Larsson LG
Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
[TBL] [Abstract][Full Text] [Related]
15. Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.
Guo XL; Pan L; Zhang XJ; Suo XH; Niu ZY; Zhang JY; Wang F; Dong ZR; Da W; Ohno R
Leuk Lymphoma; 2007 Jun; 48(6):1200-7. PubMed ID: 17577784
[TBL] [Abstract][Full Text] [Related]
16. Mad proteins contain a dominant transcription repression domain.
Ayer DE; Laherty CD; Lawrence QA; Armstrong AP; Eisenman RN
Mol Cell Biol; 1996 Oct; 16(10):5772-81. PubMed ID: 8816491
[TBL] [Abstract][Full Text] [Related]
17. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
18. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
[TBL] [Abstract][Full Text] [Related]
19. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA
Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639
[TBL] [Abstract][Full Text] [Related]
20. Mxi1-0, an alternatively transcribed Mxi1 isoform, is overexpressed in glioblastomas.
Engstrom LD; Youkilis AS; Gorelick JL; Zheng D; Ackley V; Petroff CA; Benson LQ; Coon MR; Zhu X; Hanash SM; Wechsler DS
Neoplasia; 2004; 6(5):660-73. PubMed ID: 15548375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
